The impact of the rs6971 polymorphism in TSPO for quantification and study design
Second-generation translocator protein (TSPO) radioligands were developed to circumvent the technical short comings of 11C-PK11195, the first TSPO targeting tracer. However, in early clinical positron emission tomography (PET) studies they displayed greater inter- and intra-subject variability than was expected given the promising characteristics they showed in preclinical and in vitro studies. A great deal of this variability, although not all, can be explained by the rs6971 polymorphism in the gene encoding TSPO. This polymorphism causes a single amino acid substitution in the TSPO which, for all second-generation tracers tested in man hitherto, reduces binding affinity in mutants relative to wild type. This has obvious implications for interpretation of data, because inter-subject comparisons in PET studies are predicated on the assumption that binding affinity is consistent across all subjects. In this paper, we discuss the implications of the rs6971 polymorphism on study design, analysis and interpretation of data for clinical PET studies using second-generation TSPO radioligands.
KeywordsTSPO PET imaging rs6971 polymorphism
Compliance with ethical standards
This review was not funded. This is a review paper, and as such no experiments were performed, and hence no animals or humans were involved and no approval was required.
Conflict of interest
D. R. Owen declares that he has no conflict of interest. Q. Guo declares that she has no conflict of interest. E. A. Rabiner declares that he has no conflict of interest. R. N. Gunn declares that he has no conflict of interest.
- 5.Fujita M, Imaizumi M, Zoghbi SS, Fujimura Y, Farris AG, Suhara T et al (2008) Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 40(1):43–52CrossRefPubMedGoogle Scholar
- 16.Kreisl WC, Jenko KJ, Hines CS, Lyoo CH, Corona W, Morse CL et al (2013) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 33(1):53–58CrossRefPubMedGoogle Scholar
- 17.Kobayashi M, Jenko K, Zoghbi S, Lohith T, Rallis-Frutos D, Page E, Ikawa M, Pike V, Innis R, Fujita M (2015) Blockade of translocator protein (TSPO) to measure specific binding of 11C-(R)-PK 11195 in human brain. J Nucl Med 56:467Google Scholar